Head & Neck/Thyroid Cancers
Conference Coverage
Percutaneous ethanol effective for small papillary thyroid cancers
Key clinical point: Ultrasound-guided percutaneous ethanol ablation (UPEA) is an efficacious, cost-effective, and noninvasive definitive treatment...
News
RFA, ethanol ablation equally effective for thyroid nodules
Key clinical point: Radiofrequency ablation and ethanol ablation were similarly effective in treating cystic thyroid nodules. Major finding: At 6...
Conference Coverage
ITC: SELECT trial: Lenvatinib effects similar regardless of site, number of metastases
Outcomes in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib did not differ based on metastatic site,...
Conference Coverage
Thyroglobulin can’t predict pazopanib response in differentiated thyroid cancer
Key clinical point: Falling thyroglobulin levels cannot predict early response to pazopanib in differentiated thyroid cancers. Major finding:...
Conference Coverage
Cabozantinib shows promise in refractory differentiated thyroid cancer
Most patients with differentiated thyroid cancer who had shown progression on previous courses of targeted chemotherapy either maintained stable...
Conference Coverage
ITC 2015: TIRADS scoring helps sort out malignancy after fine-needle aspiration of thyroid nodule
A scoring system for ultrasound evaluation of thyroid nodules is useful in predicting malignancy in cases of atypia of unknown significance but is...
Conference Coverage
Cabozantinib boosts survival for some patients with RET+ medullary thyroid cancer
Key clinical point: Cabozantinib improved overall survival in RET-M918T–positive progressive medullary thyroid cancers. Major finding: Compared to...
Conference Coverage
Obesity linked with more aggressive papillary thyroid carcinoma
Obesity was strongly associated with more aggressive papillary thyroid carcinoma features, but not with a greater likelihood of disease recurrence...